Page 1375 - Cote clinical veterinary advisor dogs and cats 4th
P. 1375

693.e2  Neutropenia, Immune-Mediated




            Neutropenia, Immune-Mediated                                                           Client Education
                                                                                                         Sheet
  VetBooks.ir

            BASIC INFORMATION
                                              marrow evaluation is usually necessary to
                                              decide and determine appropriate treatment   metric Neutrophil Surface Antibody Flow
                                                                                     test.
           Definition                         and  prognosis.  Usually,  immune-mediated   •  Any  concurrent  drug  therapy  should  be
           Antibody-mediated destruction of neutrophils   neutropenia is a diagnosis of exclusion.  stopped if possible to rule out adverse drug
           and/or their precursors in the marrow, result-                          reaction.
           ing in a decrease in the absolute number of   Differential Diagnosis  •  Response to treatment with corticosteroids
           circulating neutrophils            •  Secondary  neutropenia,  often  with  toxic   may allow retrospective diagnosis of immune-
                                                changes on blood smear, is usually associated   mediated neutropenia.
           Synonym                              with severe illness and may improve within
           Steroid-responsive neutropenia       days of appropriate antibiotic treatment;    TREATMENT
                                                conversely, primary neutropenia persists
           Epidemiology                         after an infection is treated.   Treatment Overview
           SPECIES, AGE, SEX                  •  Primary but nonimmune-mediated neutro-  Assume sepsis exists when fever and neutropenia
           •  Rare cause of neutropenia but more common   penia                  are present concurrently, regardless of the cause
            in dogs than cats                   ○   Bone marrow abnormality such as aplasia,   of the neutropenia. Intensive treatment with
           •  Any age; female dogs < 4 years old may be   fibrosis, dysplasia, or neoplasia; neutrope-  IV bactericidal antibiotics is indicated because
            at increased risk.                    nia occurs first, then thrombocytopenia   sepsis can be rapidly fatal. Glucocorticoids can
                                                  and anemia                     be added later if primary immune-mediated
           GENETICS, BREED PREDISPOSITION       ○   Infections such as parvovirus or ehrlichiosis   disease remains the most likely diagnosis by
           •  One  report  involved  three  female  giant   in dogs and retroviruses (FeLV, FIV) or   exclusion.
            schnauzers.                           panleukopenia in cats
           •  Cats and Belgian Tervuren dogs may have   ○   Hyperestrogenism from testicular or   Acute General Treatment
            physiologic neutropenia without clinical signs.  ovarian tumors or iatrogenic estrogen   •  Weigh  risks  and  benefits,  and  rule  out
                                                  administration                   other causes of neutropenia before starting
           RISK FACTORS                       •  Cyclic neutropenia in gray collies is a rare   glucocorticoid therapy.
           Drugs (phenylbutazone, griseofulvin  [cats])   cause of neutropenia, as is trapped neutrophil   •  Use appropriate antibiotics based on C&S
           or infectious agents (viruses, rickettsiae) are   syndrome of Border collies.  if fever is present. Empirical antibiotic
           sometimes implicated.              •  Some  normal  cats  may  have  neutrophil   treatment  may be necessary initially  (first
                                                counts between 1800 and 2500/mcL.  few days) while C&S is underway.
           ASSOCIATED DISORDERS                                                    ○   In  severely  ill  patients,  IV  antibiotics
           Sometimes concurrent anemia, thrombocytope-  Initial Database             should be used. Options include cefoxitin
           nia, or pancytopenia or other immune-mediated   •  CBC: if the neutropenia is associated with   30 mg/kg IV q 6-8h, or ampicillin 20 mg/
           diseases                             other cytopenias or it persists for more than   kg  IV  q  8h  plus  enrofloxacin  5 mg/kg
                                                2-3 days (if  <  1000/mcL  neutrophils)  or   (diluted 1 : 1 with sterile saline and given
           Clinical Presentation                1 week (if 1000-2000/mcL), bone marrow   slowly IV) q 12h (5 mg/kg q 24h in cats).
           HISTORY, CHIEF COMPLAINT             aspiration and biopsy are indicated.  ○   In severe sepsis, consider temporary use
           •  Sometimes an incidental finding on CBC   ○   Neutrophil counts are usually < 500/mcL   of human granulocyte colony-stimulating
            for healthy pets                      at presentation for immune-mediated   factor  (G-CSF  5)  mcg/kg  SQ  q  24h.
           •  Lethargy or anorexia may be reported.  neutropenia.                    Development of antibodies prevents
           •  Signs  may  arise  from  infections,  usually   •  Serum  biochemistry  profile  and  possibly   long-term benefits.
            bacterial from invasion of normal flora.  thoracic and abdominal radiographs may   ○   In stable cases, oral trimethoprim-sulfadiazine
           •  Clinical  signs  are  nonspecific  and  usually   disclose an underlying disorder (infection   15 mg/kg PO q 12h is often suitable because
            are not helpful in localizing infections.  or neoplasia) causing secondary neutropenia.  it preserves normal intestinal anaerobes.
                                                ○   Serum chemistry profile is usually unre-  Trimethoprim-sulfadiazine has rarely been
           PHYSICAL EXAM FINDINGS                 markable, although hyperglobulinemia   implicated as a cause of neutropenia.
           Fever and weakness may be the only findings.   may be present.        •  Prophylactic  antibiotic  treatment  may  be
           Sometimes signs of opportunistic infections   ○   Possible thoracic radiographic lesions   warranted even for afebrile animals with
           (e.g., diarrhea, gingivitis, skin lesions) may   (e.g., mediastinal or pulmonary disease)   severe neutropenia.
           be present.                            if secondary infection present  •  Prevent infection by paying special attention
                                              •  Urinalysis with bacterial culture and suscep-  to sterile technique with IV catheters and
           Etiology and Pathophysiology         tibility (C&S) to evaluate for urinary tract   other invasive procedures.
           •  Idiopathic; possibly genetic predisposition;   infection           •  Start  prednisone  at  2 mg/kg  PO  q  24h
            not well studied                                                       after infectious causes have been ruled out
           •  Drugs or infections occasionally implicated  Advanced or Confirmatory Testing  or treated. Continue until neutrophil count
                                              •  Abdominal ultrasonography to evaluate for   is normal.
            DIAGNOSIS                           evidence of neoplasia or infection  •  If risk of ehrlichiosis, consider doxycycline
                                              •  Serologic  testing  for  relevant  infectious   5-10 mg/kg  PO  q  24h  while  awaiting
           Diagnostic Overview                  diseases                           serologic test results.
           Neutropenia may be primary or secondary   •  Antineutrophil  antibodies  have  been
           to an overwhelming infection. Determining   demonstrated by flow cytometric immu-  Chronic Treatment
           which exists in a given patient is of paramount   nofluorescence.     •  With immune-mediated neutropenia, neu-
           importance. A combination of physical exam,   ○   The  University  of  Tennessee  CVM   trophil count should increase < 2 weeks of
           CBCs, diagnostic imaging, and often bone   Diagnostic Laboratory offers a flow cyto-  prednisone therapy.

                                                     www.ExpertConsult.com
   1370   1371   1372   1373   1374   1375   1376   1377   1378   1379   1380